| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.42B | 15.53B | 14.18B | 13.02B | 12.34B | 10.99B |
| Gross Profit | 5.95B | 6.06B | 5.68B | 5.03B | 4.65B | 4.06B |
| EBITDA | 1.01B | 785.85M | 1.08B | 1.15B | 1.55B | 630.63M |
| Net Income | 742.46M | 335.27M | 680.12M | 1.11B | 1.01B | 151.08M |
Balance Sheet | ||||||
| Total Assets | 10.35B | 11.30B | 11.89B | 9.95B | 8.94B | 6.99B |
| Cash, Cash Equivalents and Short-Term Investments | 4.11B | 5.62B | 5.83B | 5.87B | 5.30B | 3.37B |
| Total Debt | 877.49M | 1.20B | 1.50B | 829.71M | 924.05M | 575.64M |
| Total Liabilities | 4.71B | 5.52B | 5.98B | 4.50B | 4.33B | 3.29B |
| Stockholders Equity | 4.79B | 4.63B | 4.77B | 4.30B | 3.47B | 2.75B |
Cash Flow | ||||||
| Free Cash Flow | 700.82M | 601.54M | 983.65M | 1.15B | 1.78B | 372.50M |
| Operating Cash Flow | 850.29M | 710.59M | 1.18B | 1.43B | 1.93B | 558.50M |
| Investing Cash Flow | -123.71M | -30.80M | -915.92M | -331.46M | 42.25M | -136.84M |
| Financing Cash Flow | -1.01B | -882.39M | -320.84M | -564.12M | -118.58M | -432.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥15.71B | 21.04 | ― | 1.96% | 0.16% | 116.15% | |
67 Neutral | ¥10.10B | 23.76 | ― | 3.92% | 2.87% | 27.30% | |
66 Neutral | ¥508.67B | 20.21 | ― | 1.12% | 5.90% | 17.39% | |
62 Neutral | ¥11.24B | 29.91 | ― | 0.91% | 8.13% | 275.53% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
59 Neutral | ¥26.51B | 41.90 | ― | 1.11% | -4.66% | -56.66% | |
52 Neutral | ¥55.10B | 25.12 | 0.69% | 4.16% | 11.52% | 162.04% |